Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Dosage Forms × 1 year × Clear all

Sponsor

Conditions

Vomiting 1 Substance-Related Disorders 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Neurofibromatosis 1 1 Motor Activity 1 Lymphoma, Follicular 1 Lymphoma 1 Hematologic Neoplasms 1 Breast Neoplasms 1 Acromegaly 1

Interventions

enzalutamide 81 Magnetic Resonance Spectroscopy 79 Specimen Handling 59 Prednisone 59 Abiraterone Acetate 56 apalutamide 49 Radiosurgery 48 Androgen Antagonists 48 Leuprolide 43 Radiotherapy 41 Docetaxel 37 darolutamide 35 abiraterone 32 Pluvicto 30 Radiation 28 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 27 Biopsy 27 pembrolizumab 24 gallium 68 PSMA-11 24 Goserelin 23 relugolix 22 Surveys and Questionnaires 22 Standard of Care 22 Brachytherapy 21 bicalutamide 20 Triptorelin Pamoate 20 Gonadotropin-Releasing Hormone 19 Carboplatin 19 cabazitaxel 18 olaparib 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡